IBM Falls as Fallen Anthropic Puts Them in Crosshairs
IBM stock slides as Anthropic's AI code tool threatens IBM's COBOL modernization business, forcing investors to repri...
Ways To Increase Your Savings Rate
Discover effective ways to increase your savings rate, helping you reach your financial goals faster.
22,196 articles
271% Years: Is Antero Midstream the Stock to Own Now?
Antero Midstream logged 271% total returns over three years and closed a $1.1 billion Marcellus asset deal. The 2026 ...
Pepe Explodes Amid Altcoin Rally as BTC Tops $74K Again
Bitcoin climbs to a six-week peak near $74,000 as pepe explodes amid altcoin momentum. Major tokens follow, with ETH ...
Massive Wind Farm Offshore Massachusetts Completes
Massachusetts’ Vineyard Wind project has completed construction, delivering 800 MW to the region and signaling a majo...
Meta vs Netflix: These Stocks May Double in 2026 This Year
Market bifurcation put Meta Platforms and Netflix on opposite growth tracks in early 2026. One path could double asse...
World Carvana Buying Brick-And-Mortar: Investing Insight
Carvana’s pivot from pure online disruption to owning physical dealerships is surprising. This piece breaks down why ...
NVIDIA Stock Price Prediction: 2026-2030 Outlook Revealed
NVIDIA riding robust AI demand, elevated data-center spending, and resilient margins as 2026 unfolds. Analysts weigh ...
Novo Nordisk Stock Outlook 2026–2030: Forecasts and Risks
Analysts project a multi-year path for novo nordisk (nvo) stock, supported by strong product momentum but tempered by...
U.S. Just Trillion Debt: Why Action Stalls Now in Congress
The federal debt breached $39 trillion this week as lawmakers debated a constitutional fix that failed to pass. The p...
LAC Stock Rises 32% Over Past Year Amid Dilution
Lithium Americas has gained 32% in the last year as Thacker Pass advances, but rising share dilution and mounting cap...
Micron Drops Despite Strong Earnings: A Market Disconnect
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status